City State Bank Sells 95 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

City State Bank lessened its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 1.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 8,425 shares of the financial services provider’s stock after selling 95 shares during the period. City State Bank’s holdings in iShares Biotechnology ETF were worth $1,114,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in IBB. Darwin Wealth Management LLC bought a new stake in iShares Biotechnology ETF during the third quarter worth $29,000. Highline Wealth Partners LLC bought a new position in iShares Biotechnology ETF in the third quarter valued at about $30,000. Ashton Thomas Securities LLC acquired a new position in iShares Biotechnology ETF during the third quarter worth about $36,000. Modus Advisors LLC bought a new position in shares of iShares Biotechnology ETF in the fourth quarter worth about $41,000. Finally, Voisard Asset Management Group Inc. acquired a new stake in shares of iShares Biotechnology ETF in the 3rd quarter valued at approximately $59,000. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Trading Down 0.5 %

Shares of iShares Biotechnology ETF stock traded down $0.64 during midday trading on Monday, hitting $132.09. 374,029 shares of the company traded hands, compared to its average volume of 1,292,558. The firm’s fifty day moving average price is $137.95 and its 200-day moving average price is $141.99. iShares Biotechnology ETF has a 12 month low of $123.60 and a 12 month high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were issued a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.